Perfect is the enemy of good enough. I agree with your assessment, that a pill is not ideal current state of the art, but if a pill format improves compliance and delivery vs injectables, and the cost of the pill can be driven down to where it is similar to Metformin, the outcome is still the same (even if there is waste from a suboptimal delivery mechanism).

An efficient drug delivery mechanism you can’t get into the hands of a broad population cohort is not efficient. We are optimizing for accessibility for everyone who needs access to this drug family (imho).